Skip to main content

and
  1. Article

    Open Access

    Experiences and challenges with the new European Clinical Trials Regulation

    The new European Medicines Agency (EMA) Clinical Trials Information System (CTIS), based on the Clinical Trials Regulation (CTR EU 536/2014), came into full effect on 31 January 2022 and was intended to provid...

    Thale D. J. H. Patrick-Brown, Josephine Bourner, Sabrina Kali, Marius Trøseid in Trials (2024)

  2. Article

    Open Access

    Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

    Baricitinib has shown efficacy in hospitalized patients with COVID-19, but no placebo-controlled trials have focused specifically on severe/critical COVID, including vaccinated participants.

    Marius Trøseid, José R. Arribas, Lambert Assoumou, Aleksander Rygh Holten in Critical Care (2023)